Great talks already from Judith James and Joel Guthridge. Looking forward to hearing from @InamoJun, Roopa Madhu, @FanZhang_Jessie, and Kevin Bu. #ACR24
Are you going to ACR Convergence? AMP® AIM and AMP RA/SLE will be hosting five oral presentations, and three posters at the conference this year!
Learn more about AMP® AIM here: ow.ly/AM1K50U6ZrI
#ACR24 #FNIH #BridgestoBreakthroughs
Nicole Beauchamp retweeted
📢 Diversity in Lupus Research Program Letters of Intent are due Sept 6!
🔬 Supports underrepresented talent in #LupusResearch and #autoimmunity by fostering growth & building a strong community of scientists & clinicians
🏆 $600K for Career Development & $200K for Postdoctoral
Nicole Beauchamp retweeted
The FNIH proudly joins @SjogrensOrg to recognize World Sjögren's Day on July 23rd to advance research and raise awareness for Sjögren's Disease. Through our Accelerating Medicines Partnership® (AMP®) for Autoimmune and Immune Mediated Diseases (AIM), we are dedicated to accelerating discoveries that improve patient outcomes. Through our Biomarkers Consortium (BC), we are leading efforts that validate and qualify biomarkers and other drug development tools for the development of new therapeutics and health technologies.
Learn more about Sjögren's Disease and how you can contribute: sjogrens.org/about-us/missio…
Learn more about AMP AIM here: fnih.org/our-programs/accele…
Learn more about the Sjögren's Biomarker project here: fnih.org/sjogrens
#ThisIsSjögrens #SjögrensAwareness #FNIH #SjögrensFoundation
Nicole Beauchamp retweeted
We're excited to announce the Be Fierce. Take Control. Mini Grant Program to raise lupus awareness among Black/African American and Hispanic/Latina women ages 18-25. HBCU and HSI faculty, staff, and students can apply by September 6, 2024. buff.ly/45ZwAsl
Nicole Beauchamp retweeted
Extremely proud and excited to share my thesis work from the Choi lab @jaehyukchoimd, in collaboration with @Deepakarao and @@vwacle, online today @Nature where we investigate pathological CXCL13+ Tph cell circuitry in SLE, online here:nature.com/articles/s41586-0…
Nicole Beauchamp retweeted
Development of effective treatments for lupus, which impacts over 1.5 million adults in the United States, have been hampered because the causes of the disease have remained elusive. Now researchers have announced a significant breakthrough in understanding the causes of lupus. Lupus patients often have an imbalanced population of immune cells crucial for controlling inflammation. This imbalance is linked to insufficient activation of aryl hydrocarbon receptor (AHR) related pathways. Boosting AHR could potentially offer a more targeted and effective lupus treatment with fewer side effects.
This opens new avenues for combating lupus and other autoimmune diseases and the FNIH-led Accelerating Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program is pleased to have played a key role in this research.
Read more here news.feinberg.northwestern.e…
#Lupus #ARH #autoimmunedisease #AMP #AMPRASLE #FNIH #BridgestoBreakthroughs #rheumatoidarthritis #SLE #SystemicLupusErythematosus
An amazing new paper from @jaehyukchoimd & @Deepakarao showing AHR, JUN & #IFN as key regulators of CXCL13+ TPH/TFH #Tcell states in #lupus pathogenesis.
@FNIH_Org #TeamScience
nature.com/articles/s41586-0…
1
3
240
Nicole Beauchamp retweeted
Apply for Editor-in-Chief (EIC) of ImmunoHorizons (IH): Champion Immunology's Impact on Public Health.” Queries can be directed to [email protected].
Nicole Beauchamp retweeted
Granzyme F is a marker of terminally differentiated CD8 T cells with increased cytotoxicity, but also increased self-directed cytotoxicity, suggesting a potential mechanism for the end of the terminal exhaustion pathway @J_Immunol
doi.org/10.4049/jimmunol.230…
Nicole Beauchamp retweeted
Plitidepsin as immunomodulator reducing IL-6 and other proinflammatory cytokines to improve immunity against respiratory viral infections @J_Immunol
doi.org/10.4049/jimmunol.230…
Nicole Beauchamp retweeted
🚨 #CuttingEdge 🚨 This study by Arnett et al. @txbiomed demonstrates how mycobacteria #infection impacts AIM2 expression in #macrophages & highlights key signaling events needed for IL1 production. #ReadTheJI #immunology
ow.ly/wCkb50QIoN3
Nicole Beauchamp retweeted
Check out all @ImmunologyAAI journals' collections, including: #BriefReviews, #PillarsofImmunology, special issues on #MaternalFetalImmunology, the #Microbiome, & more @J_immunol; and #ImmunologyEducation and #OntheHorizon articles @ImmunoHorizons 👉 journals.aai.org/collections
Nicole Beauchamp retweeted
#BriefReview by Luxia Xu, Feiyan Pan, & Zhigang Guo discussing “TIPE2: A Candidate for Targeting Antitumor #Immunotherapy”
#ReadTheJI #immunology #cancerimmunoloyg 👉 ow.ly/pwEz50QIoLP
Nicole Beauchamp retweeted
#JI_TopRead #FreetoRead from Toshihiko Toyofuku @OsakaU_Research: anti-FMR1NB chimeric Ag receptors in 2DG-treated T cells offers a new strategy for #immunotherapy against solid tumors
#AuthorChoice #ReadTheJI #immunology #cancerimmunology 👉 ow.ly/YEin50QIoJT
Nicole Beauchamp retweeted
#JI_TopRead from María Adelaida Gómez @txbiomed: systemic treatment of #cutaneousleishmaniasis with Glucantime & miltefosine ® strong transcriptional programs of #woundhealing & inflammation
#ReadTheJI #immunology #skinimmunity # Leishmaniasis 👉 ow.ly/sVFX50QIoHP
And fully open access for only $1595!
IF YOU COME FOR ME, I’M GOING TO TELL YOU ABOUT @ImmunoHorizons A PERFECT JOURNAL FOR SUBMITTING YOUR INCREMENTAL AND DESCRIPTIVE FINDINGS. AND TOTALLY LEGAL! ih.msubmit.net
Nicole Beauchamp retweeted
Apply apply apply!! We would love some awesome new colleagues to join us in gorgeous NM as tenure track faculty @BlackInNeuro @BlackInChem @BlackinPhysics @BlkInData @BlackinPsych @LatinXChem @latinxdata @IndigiData @NativeBio @natblackpostdoc @Nati
Our next deadline is tomorrow, Aug. 8! Make sure view all application criteria and we look forward to learning more about you! Apply here: unmfirst.unm.edu/apply-now/i…
#academictwitter #neuroscience #DataScience
Nicole Beauchamp retweeted
TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells @J_Immunol @Swartz_lab
doi.org/10.4049/jimmunol.220…
Nicole Beauchamp retweeted
Molecular Mechanisms of Lupus Susceptibility Allele PBX1D @J_Immunol MorelLab
doi.org/10.4049/jimmunol.230…
Nicole Beauchamp retweeted
Polycomb Repressive Complex 1 Subunit Cbx4 Positively Regulates Effector Responses in CD8 T Cells @J_Immunol @Martinez_G_J Renata Pereira
doi.org/10.4049/jimmunol.220…




















